June 3, 2024

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

Join us for the NRG Oncology Summer Meeting July 25th - July 27th at the Sheraton Denver Downtown Hotel in Denver, CO. The Meeting will be held in-person only (with limited virtual session offerings). 

AMENDMENTS

Darolutamide Action Letter Amendments

The following protocol amendments are response to an NCI action letter dated May 24, 2024, for CTEP-supported studies that involve darolutamide:

NRG-GU010: Amendment 2; version date: May 6, 2024 (posted on CTSU)

NRG-GY033: Amendment 2; version date: May 1, 2024 (posted on CTSU)

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Reminder: Actively Recruiting MALE Patients only Read More

2. BIOSPECIMEN BANKS

Printing Biospecimen Transmittal PDFs from Rave

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

3. CANCER PREVENTION & CONTROL

NRG-CC010: The study is open to NRG sites in Japan and South Korea. The optional biospecimen collection does not apply to sites participating in these countries.

4. GASTROINTESTINAL

NRG-GI008/CIRCULATE-North America: Please see the memorandum dated May 30, 2024, regarding e-mail communication from Natera (posted on CTSU).

NRG-GI008/CIRCULATE-North America: Study overview webinars are being held via Microsoft Teams on June 11 at 11am ET and June 13 at 2pm ET. Please see the memorandum, dated May 9, 2024, (posted on CTSU) for details and how to register for one of the sessions. Please note: Google Chrome is the preferred browser to register for the webinars.

5. GENITOURINARY

NRG-GU010: Amendment 2 Spanish Consent form, dated May 6, 2024 posted on CTSU.

NRG-GU011: Updated Study overview slides, dated May 28, 2024, posted to CTSU.

6. GYNECOLOGIC

GOG-0210: Reminder: Biospecimens, biomarker data, clinical data, and epidemiologic data are available for request. Please visit the NRG Oncology website for more information on this important study with the overall goal of improving the outcome and/or quality of life for patients with endometrial cancer.

NRG-GY031: Please note, there is an error in the section 4.2 table and the Biospecimen Collection and Submission Manual. The Part I PK collection is to be done on Cycle 1, Day 1, and Cycle 1, Day 8. This will be updated with the next amendment.

7. HEAD & NECK

NRG-HN008 - Reminder: please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important. 

8. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, NRG-BR009, NRG-CC011, and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, June 12, 2024.

Drug Safety and Investigator’s Brochure (IB) updates have been issued for the following studies:

NRG Mentorship Working Group Update

Are you a new CRA or CTN within NRG Oncology? Would you like a mentor to help guide you through your new role as a CRA or CTN? Are you an institution in need of more guidance after an audit? The Mentorship Working Group can provide you with a mentor! You can apply for a mentor by going to the Introductory Materials page on the NRG website. You will find the Mentor Form to complete. The instructions on how to submit are located on the form. Hope to hear from you soon!

NRG Oncology seeks to fill the position of Vice-Chair, NRG Oncology Early Phase Trial Oversight Committee

Application Deadline: June 14, 2024

We are seeking nominations for the position of Vice-Chair, NRG Early Phase Trial Oversight Committee. This committee is one of five oversight committees which help to guide, review and evaluate, and implement clinical trials in accordance with the group's strategic themes, strengths, and the research needs of the overall National Clinical Trials Network. Read more here

NRG Oncology 2024 ASCO Presentations

The flyer is now available for all NRG Oncology 2024 ASCO presentations here on the NRG website.

Please note the following upcoming meetings and abstract submission deadlines

UPCOMING MEETINGS

American Brachytherapy Society (ABS) World Congress; Jul 10-13, 2024; National Harbor, MD

American Society of Clinical Oncology (ASCO); May 31-Jun 4, 2024; Chicago, IL

American Society of Colon and Rectal Surgeons (ASCRS); Jun 1-4, 2024; Baltimore, MD

European Society for Medical Oncology (ESMO); Sep 13-17, 2024; Barcelona, Spain

European Society for Medical Oncology (ESMO) Gastrointestinal; Jun 26-29, 2024; Munich, Germany

European Society for Medical Oncology (ESMO) Gynaecological; Jun 20-22, 2024; Florence, Italy

International Society for Quality-of-Life Research (ISOQOL); Oct 13-16, 2024; Cologne, Germany

PA Breast Cancer Coalition (PBCC); Oct 15, 2024; Harrisburg, PA

Radiological Society of North America (RSNA); Dec 1-5, 2024; Chicago, IL



Western Association of Gynecologic Oncologists (WAGO); Jun 12-15, 2024; Seattle, WA

UPCOMING ABSTRACT SUBMISSION DEADLINES

American Society for Radiation Oncology (ASTRO); Sep 29-Oct 2, 2024; Washington, DC; LBA Jul 12, 2024

EORTC-NCI-AACR Symposium on Molecular Targets and therapies; Oct 23-25, 2024; Barcelona, Spain; due to publications committee Jun 13, 2024; submission deadline Jun 27, 2024; LBA Sep 26, 2024

European Society of Gynaecological Oncology (ESGO); Feb 20-23, 2025; Rome, Italy; due to publications committee Oct 14, 2024; submission deadline Oct 28, 2024; LBA Jan 15, 2025 (placeholder required)

International Gynecologic Cancer Society (IGCS); Oct 16-18, 2024; Dublin, Ireland; LBA Jul 2, 2024, 23:59 IST

San Antonio Breast Cancer Society (SABCS); Dec 10-14, 2024; San Antonio, TX; due to publications committee Jun 26, 2024; submission deadline Jul 10, 2024, 11:59 pm CT; LBA Sep 30, 2024, 11:59 pm CT

Society for Immunotherapy of Cancer (SITC); Nov 6-10, 2024; Houston, TX; submission deadline Jun 27, 2024; LBA Sep 12, 2024

Society for Neuro-Oncology (SNO); Nov 21-24, 2024; Houston, TX; submission deadline May 29, 2024, 11:59 pm ET; LBA Sep 3, 2024, 5:00 pm ET (placeholder required)